The EU’s medtech regulatory authorities recognize there is an urgent need to develop and improve the medtech regulatory system, but say that “doing so reactively and without a thorough analysis and evaluation could lead to significant further disruption and impairment to progress towards an effective EU regulatory system.”
“Taking a wrong turn at this point is not an option,” the Competent Authorities for Medical Devices (CAMD) association adds in a recent statement endorsed by authorities in 20...